Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Bolton-Maggs

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Journal of Pediatric Hematology/Oncology|December 12, 2003
Severe bleeding in idiopathic thrombocytopenic purpuraPaula Bolton-Maggs
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Comments on 'clinical course of 63 children with hereditary spherocytosis: a retrospective study' - with the particular question: 'Should HS be treated the same way throughout the world?'Paula Bolton-Maggs
Transfusion Medicine (Oxford, England)|March 21, 2012
Commentary on Keidan 2012: routine antenatal anti-D prophylaxis - is the protection adequate?Paula Bolton-Maggs
Pediatric Blood & Cancer|June 27, 2013
Diagnosis and management of thrombotic microangiopathy: the role of registriesPaula Bolton-Maggs
Transfusion Medicine (Oxford, England)|September 14, 2020
Pulmonary complications of transfusion: Changes, challenges, and future directionsSharran Grey, Paula Bolton-Maggs
Pediatric Clinics of North America|April 3, 2008
Childhood immune thrombocytopenic purpura: diagnosis and managementVictor Blanchette, Paula Bolton-Maggs
Hematology/Oncology Clinics of North America|February 2, 2010
Childhood immune thrombocytopenic purpura: diagnosis and managementVictor Blanchette, Paula Bolton-Maggs
British Journal of Haematology|August 16, 2002
The use of vitamin K for reversal of over-warfarinization in childrenPaula Bolton-Maggs, Lynda Brook
BMJ (Clinical Research Ed.)|September 13, 2005
Epirubicin for breast cancer may cause considerable venous sclerosisPaula Bolton-Maggs, Aileen Flavin
Nursing Times|April 2, 2014
Patient identification in blood samplingAnne Davidson, Paula Bolton-Maggs
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Journal of Pediatric Hematology/Oncology|December 12, 2003
Severe bleeding in idiopathic thrombocytopenic purpuraPaula Bolton-Maggs
Revista Brasileira De Hematologia E Hemoterapia|October 11, 2012
Comments on 'clinical course of 63 children with hereditary spherocytosis: a retrospective study' - with the particular question: 'Should HS be treated the same way throughout the world?'Paula Bolton-Maggs
Transfusion Medicine (Oxford, England)|March 21, 2012
Commentary on Keidan 2012: routine antenatal anti-D prophylaxis - is the protection adequate?Paula Bolton-Maggs
Pediatric Blood & Cancer|June 27, 2013
Diagnosis and management of thrombotic microangiopathy: the role of registriesPaula Bolton-Maggs
Transfusion Medicine (Oxford, England)|September 14, 2020
Pulmonary complications of transfusion: Changes, challenges, and future directionsSharran Grey, Paula Bolton-Maggs
Pediatric Clinics of North America|April 3, 2008
Childhood immune thrombocytopenic purpura: diagnosis and managementVictor Blanchette, Paula Bolton-Maggs
Hematology/Oncology Clinics of North America|February 2, 2010
Childhood immune thrombocytopenic purpura: diagnosis and managementVictor Blanchette, Paula Bolton-Maggs
British Journal of Haematology|August 16, 2002
The use of vitamin K for reversal of over-warfarinization in childrenPaula Bolton-Maggs, Lynda Brook
BMJ (Clinical Research Ed.)|September 13, 2005
Epirubicin for breast cancer may cause considerable venous sclerosisPaula Bolton-Maggs, Aileen Flavin
Nursing Times|April 2, 2014
Patient identification in blood samplingAnne Davidson, Paula Bolton-Maggs
Pageof 4